North Carolina Newborn Exome Sequencing for Universal Screening

Completed · Not applicable

Conditions studied: Metabolism, Inborn Errors, Hearing Loss, Hereditary Disease

In brief

The NC NEXUS research study is exploring the utility of next generation sequencing in newborn screening and parental decision making. The National Institutes of Health (NICHD and NHGRI) are co-funding this study under a single U-19.

Key facts

Study ID

NCT02826694

Run by

University of North Carolina, Chapel Hill

People needed

106

Starts

2016-06-01

Expected to finish

2019-06-30

Last updated by the study team

2020-07-08

Who can join

Age: any, up to 5. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Uncomplicated pregnancy and healthy newborn

You may not qualify if…

• Abnormalities such as major malformation or chromosomal disorder detected prenatally or significant complications during pregnancy or at the time of delivery.

Where it is running

• UNC Hospitals — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.